These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FORM 10-Q
|
|
[x]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
|
|
|
|
QUICKLOGIC CORPORATION
|
||
|
(Exact name of registrant as specified in its charter)
|
||
|
|
|
|
|
DELAWARE
|
|
77-0188504
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
|
|
[ ]
|
|
Accelerated Filer
|
|
[x]
|
|
|
|
|
|
|
|
|
|
Non-accelerated filer
|
|
[ ] (Do not check if a smaller reporting company)
|
|
Smaller Reporting Company
|
|
[ ]
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
[ ]
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
||
|
|
July 2,
2017 |
|
January 1,
2017 |
||||
|
ASSETS
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
22,234
|
|
|
$
|
14,870
|
|
|
Accounts receivable, net of allowances for doubtful accounts of $0 and $0
|
1,051
|
|
|
839
|
|
||
|
Inventories
|
3,322
|
|
|
2,017
|
|
||
|
Other current assets
|
868
|
|
|
1,123
|
|
||
|
Total current assets
|
27,475
|
|
|
18,849
|
|
||
|
Property and equipment, net
|
2,529
|
|
|
2,765
|
|
||
|
Other assets
|
236
|
|
|
230
|
|
||
|
TOTAL ASSETS
|
$
|
30,240
|
|
|
$
|
21,844
|
|
|
|
|
|
|
|
|
||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
|
||
|
Revolving line of credit
|
$
|
6,000
|
|
|
$
|
6,000
|
|
|
Trade payables
|
1,227
|
|
|
2,018
|
|
||
|
Accrued liabilities
|
1,648
|
|
|
1,580
|
|
||
|
Deferred revenue
|
79
|
|
|
—
|
|
||
|
Current portion of capital lease obligations
|
167
|
|
|
209
|
|
||
|
Total current liabilities
|
9,121
|
|
|
9,807
|
|
||
|
Long-term liabilities:
|
|
|
|
|
|
||
|
Capital lease obligations, less current portion
|
129
|
|
|
—
|
|
||
|
Other long-term liabilities
|
35
|
|
|
49
|
|
||
|
Total liabilities
|
9,285
|
|
|
9,856
|
|
||
|
Commitments and contingencies (see Note 12)
|
|
|
|
|
|||
|
Stockholders' equity:
|
|
|
|
|
|||
|
Preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, $0.001 par value; 200,000 and 100,000 shares authorized as of July 2, 2017 and January 1, 2017, respectively; 80,103 and 68,134 shares issued and outstanding as of July 2, 2017 and January 1, 2017, respectively
|
80
|
|
|
68
|
|
||
|
Additional paid-in capital
|
267,951
|
|
|
251,824
|
|
||
|
Accumulated deficit
|
(247,076
|
)
|
|
(239,904
|
)
|
||
|
Total stockholders' equity
|
20,955
|
|
|
11,988
|
|
||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
30,240
|
|
|
$
|
21,844
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
July 2, 2017
|
|
July 3, 2016
|
|
July 2, 2017
|
|
July 3, 2016
|
||||||||
|
Revenue
|
$
|
3,026
|
|
|
$
|
2,717
|
|
|
$
|
6,196
|
|
|
$
|
5,667
|
|
|
Cost of revenue
|
1,646
|
|
|
1,941
|
|
|
3,443
|
|
|
3,735
|
|
||||
|
Gross profit
|
1,380
|
|
|
776
|
|
|
2,753
|
|
|
1,932
|
|
||||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
||||||
|
Research and development
|
2,319
|
|
|
3,683
|
|
|
4,746
|
|
|
7,130
|
|
||||
|
Selling, general and administrative
|
2,614
|
|
|
2,591
|
|
|
5,028
|
|
|
5,284
|
|
||||
|
Total operating expenses
|
4,933
|
|
|
6,274
|
|
|
9,774
|
|
|
12,414
|
|
||||
|
Loss from operations
|
(3,553
|
)
|
|
(5,498
|
)
|
|
(7,021
|
)
|
|
(10,482
|
)
|
||||
|
Interest expense
|
(21
|
)
|
|
(34
|
)
|
|
(82
|
)
|
|
(72
|
)
|
||||
|
Interest income and other (expense), net
|
1
|
|
|
(15
|
)
|
|
1
|
|
|
(22
|
)
|
||||
|
Loss before income taxes
|
(3,573
|
)
|
|
(5,547
|
)
|
|
(7,102
|
)
|
|
(10,576
|
)
|
||||
|
Provision for income taxes
|
34
|
|
|
27
|
|
|
70
|
|
|
91
|
|
||||
|
Net loss
|
$
|
(3,607
|
)
|
|
$
|
(5,574
|
)
|
|
$
|
(7,172
|
)
|
|
$
|
(10,667
|
)
|
|
Net loss per share:
|
|
|
|
|
|
|
|
|
|
||||||
|
Basic
|
$
|
(0.05
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(0.17
|
)
|
|
Diluted
|
$
|
(0.05
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(0.17
|
)
|
|
Weighted average shares:
|
|
|
|
|
|
|
|
|
|
||||||
|
Basic
|
79,799
|
|
|
67,415
|
|
|
74,327
|
|
|
62,893
|
|
||||
|
Diluted
|
79,799
|
|
|
67,415
|
|
|
74,327
|
|
|
62,893
|
|
||||
|
|
Six Months Ended
|
||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||
|
Net loss
|
$
|
(7,172
|
)
|
|
$
|
(10,667
|
)
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
||
|
Depreciation and amortization
|
709
|
|
|
631
|
|
||
|
Stock-based compensation
|
665
|
|
|
1,001
|
|
||
|
Write-down of inventories
|
104
|
|
|
235
|
|
||
|
Write-off of equipment
|
—
|
|
|
312
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||
|
Accounts receivable
|
(212
|
)
|
|
116
|
|
||
|
Inventories
|
(1,409
|
)
|
|
325
|
|
||
|
Other assets
|
265
|
|
|
357
|
|
||
|
Trade payables
|
(846
|
)
|
|
(1,816
|
)
|
||
|
Accrued liabilities
|
73
|
|
|
(43
|
)
|
||
|
Deferred revenue
|
79
|
|
|
—
|
|
||
|
Other long-term liabilities
|
(14
|
)
|
|
(13
|
)
|
||
|
Net cash used in operating activities
|
(7,758
|
)
|
|
(9,562
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Capital expenditures for property and equipment
|
(48
|
)
|
|
(1,513
|
)
|
||
|
Net cash used in investing activities
|
(48
|
)
|
|
(1,513
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Payment of capital lease obligations
|
(299
|
)
|
|
(238
|
)
|
||
|
Proceeds from line of credit
|
6,000
|
|
|
2,000
|
|
||
|
Payment of line of credit
|
(6,000
|
)
|
|
—
|
|
||
|
Proceeds from issuance of common stock
|
17,304
|
|
|
10,447
|
|
||
|
Stock issuance costs
|
(1,771
|
)
|
|
(1,197
|
)
|
||
|
Taxes for net issuance of stock awards
|
(64
|
)
|
|
(103
|
)
|
||
|
Net cash provided by financing activities
|
15,170
|
|
|
10,909
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
7,364
|
|
|
(166
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
14,870
|
|
|
19,136
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
22,234
|
|
|
$
|
18,970
|
|
|
|
|
|
|
||||
|
Supplemental schedule of non-cash investing and financing activities :
|
|
|
|
|
|
||
|
Capital lease obligation to finance capital expenditures
|
$
|
296
|
|
|
$
|
251
|
|
|
Purchase of equipment included in accounts payable
|
$
|
208
|
|
|
$
|
8
|
|
|
|
As of
|
||||||
|
|
July 2,
2017 |
|
January 1,
2017 |
||||
|
|
(in thousands)
|
||||||
|
Inventories:
|
|
|
|
||||
|
Work-in-process
|
$
|
2,354
|
|
|
$
|
1,538
|
|
|
Finished goods
|
968
|
|
|
479
|
|
||
|
|
$
|
3,322
|
|
|
$
|
2,017
|
|
|
Other current assets:
|
|
|
|
||||
|
Prepaid expenses
|
$
|
743
|
|
|
$
|
960
|
|
|
Other
|
125
|
|
|
163
|
|
||
|
|
$
|
868
|
|
|
$
|
1,123
|
|
|
Property and equipment:
|
|
|
|
||||
|
Equipment
|
$
|
11,602
|
|
|
$
|
11,524
|
|
|
Software
|
708
|
|
|
2,624
|
|
||
|
Furniture and fixtures
|
45
|
|
|
41
|
|
||
|
Leasehold improvements
|
2,772
|
|
|
708
|
|
||
|
|
15,127
|
|
|
14,897
|
|
||
|
Accumulated depreciation and amortization
|
(12,598
|
)
|
|
(12,132
|
)
|
||
|
|
$
|
2,529
|
|
|
$
|
2,765
|
|
|
|
|
|
|
||||
|
Accrued liabilities:
|
|
|
|
||||
|
Employee related accruals
|
$
|
1,252
|
|
|
$
|
1,222
|
|
|
Other
|
396
|
|
|
358
|
|
||
|
|
$
|
1,648
|
|
|
$
|
1,580
|
|
|
|
As of
|
||||||
|
|
July 2,
2017 |
|
January 1,
2017 |
||||
|
|
(in thousands)
|
||||||
|
Debt and capital lease obligations:
|
|
|
|
|
|
||
|
Revolving line of credit
|
$
|
6,000
|
|
|
$
|
6,000
|
|
|
Capital leases
|
296
|
|
|
209
|
|
||
|
|
6,296
|
|
|
6,209
|
|
||
|
Current portion of debt and capital lease obligations
|
(6,167
|
)
|
|
(6,209
|
)
|
||
|
Long-term portion of debt and capital lease obligations
|
$
|
129
|
|
|
$
|
—
|
|
|
|
July 2, 2017
|
|
January 1, 2017
|
||||||||||||||||||||||||||||
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Money market funds
(1)
|
$
|
21,576
|
|
|
$
|
6,655
|
|
|
$
|
14,921
|
|
|
$
|
—
|
|
|
$
|
14,692
|
|
|
$
|
1,338
|
|
|
$
|
13,354
|
|
|
$
|
—
|
|
|
Total assets
|
$
|
21,576
|
|
|
$
|
6,655
|
|
|
$
|
14,921
|
|
|
$
|
—
|
|
|
$
|
14,692
|
|
|
$
|
1,338
|
|
|
$
|
13,354
|
|
|
$
|
—
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
July 2,
2017 |
|
July 3,
2016 |
||||||||
|
Cost of revenue
|
$
|
20
|
|
|
$
|
47
|
|
|
$
|
53
|
|
|
$
|
85
|
|
|
Research and development
|
134
|
|
|
175
|
|
|
273
|
|
|
466
|
|
||||
|
Selling, general and administrative
|
193
|
|
|
217
|
|
|
339
|
|
|
450
|
|
||||
|
Total costs and expenses
|
$
|
347
|
|
|
$
|
439
|
|
|
$
|
665
|
|
|
$
|
1,001
|
|
|
|
Shares
Available for Grant
|
|
|
|
(in thousands)
|
|
|
Balance at January 1, 2017
|
2,632
|
|
|
Authorized
|
1,500
|
|
|
Options forfeited or expired
|
117
|
|
|
RSUs granted
|
(378
|
)
|
|
RSUs forfeited or expired
|
107
|
|
|
Balance at July 2, 2017
|
3,978
|
|
|
|
Number of Shares
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average
Remaining Term
|
|
Aggregate
Intrinsic Value
|
|||||
|
|
(in thousands)
|
|
|
|
(in years)
|
|
(in thousands)
|
|||||
|
Balance outstanding at January 1, 2017
|
4,979
|
|
|
$
|
2.35
|
|
|
|
|
|
||
|
Forfeited or expired
|
(117
|
)
|
|
$
|
2.96
|
|
|
|
|
|
||
|
Exercised
|
(53
|
)
|
|
1.31
|
|
|
|
|
|
|||
|
Balance outstanding at July 2, 2017
|
4,809
|
|
|
$
|
2.35
|
|
|
3.64
|
|
$
|
656
|
|
|
Exercisable at July 2, 2017
|
3,968
|
|
|
$
|
2.61
|
|
|
2.52
|
|
$
|
216
|
|
|
Vested and expected to vest at July 2, 2017
|
4,636
|
|
|
$
|
2.39
|
|
|
3.44
|
|
$
|
560
|
|
|
|
RSUs & PRSUs Outstanding
|
|||||
|
|
Number of Shares
|
|
Weighted Average
Grant Date Fair Value
|
|||
|
|
(in thousands)
|
|
|
|||
|
Nonvested at January 1, 2017
|
1,370
|
|
|
$
|
1.68
|
|
|
Granted
|
378
|
|
|
1.57
|
|
|
|
Vested
|
(283
|
)
|
|
1.31
|
|
|
|
Forfeited
|
(107
|
)
|
|
—
|
|
|
|
Nonvested at July 2, 2017
|
1,358
|
|
|
$
|
1.72
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
July 2,
2017 |
|
July 3,
2016 |
||||
|
Expected term (months)
|
6.00
|
|
|
6.08
|
|
|
6.00
|
|
|
6.08
|
|
|
Risk-free interest rate
|
1.02
|
%
|
|
0.40
|
%
|
|
1.02
|
%
|
|
1.04
|
%
|
|
Volatility
|
49.71
|
%
|
|
54.31
|
%
|
|
49.71
|
%
|
|
61.06
|
%
|
|
Dividend yield
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
July 2, 2017
|
|
July 3,
2016 |
||||||||
|
Revenue by product line
(1)
:
|
|
|
|
|
|
|
|
|
|
||||||
|
New products
|
$
|
1,491
|
|
|
$
|
1,197
|
|
|
$
|
3,403
|
|
|
$
|
2,689
|
|
|
Mature products
|
1,535
|
|
|
1,520
|
|
|
2,793
|
|
|
2,978
|
|
||||
|
Total revenue
|
$
|
3,026
|
|
|
$
|
2,717
|
|
|
$
|
6,196
|
|
|
$
|
5,667
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
July 2,
2017 |
|
July 3,
2016 |
||||||||
|
Revenue by geography:
|
|
|
|
|
|
|
|
|
|
||||||
|
Asia Pacific
(1)
|
$
|
1,676
|
|
|
$
|
1,779
|
|
|
$
|
3,409
|
|
|
$
|
3,506
|
|
|
North America
(2)
|
1,090
|
|
|
638
|
|
|
2,223
|
|
|
1,457
|
|
||||
|
Europe
|
260
|
|
|
300
|
|
|
564
|
|
|
704
|
|
||||
|
Total revenue
|
$
|
3,026
|
|
|
$
|
2,717
|
|
|
$
|
6,196
|
|
|
$
|
5,667
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
July 2,
2017 |
|
July 3,
2016 |
||||
|
Distributor "A"
|
33
|
%
|
|
31
|
%
|
|
32
|
%
|
|
30
|
%
|
|
Customer "B"
|
15
|
%
|
|
17
|
%
|
|
12
|
%
|
|
18
|
%
|
|
Customer "G"
|
21
|
%
|
|
31
|
%
|
|
22
|
%
|
|
33
|
%
|
|
|
July 2,
2017 |
|
January 1,
2017 |
||
|
Distributor "A"
|
41
|
%
|
|
32
|
%
|
|
Distributor "G"
|
*
|
|
|
11
|
%
|
|
Distributor "H"
|
12
|
%
|
|
13
|
%
|
|
Distributor "I"
|
*
|
|
|
15
|
%
|
|
Customer "G"
|
28
|
%
|
|
*
|
|
|
Customer "I"
|
*
|
|
|
12
|
%
|
|
*
|
Represents less than 10% of accounts receivable as of the date presented.
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||
|
|
July 2,
2017 |
July 3,
2016 |
|
July 2,
2017 |
July 3,
2016 |
||||
|
Revenue
|
100
|
%
|
100
|
%
|
|
100
|
%
|
100
|
%
|
|
Cost of revenue
|
54
|
%
|
71
|
%
|
|
56
|
%
|
66
|
%
|
|
Gross profit
|
46
|
%
|
29
|
%
|
|
44
|
%
|
34
|
%
|
|
Operating expenses:
|
|
|
|
|
|
||||
|
Research and development
|
77
|
%
|
136
|
%
|
|
77
|
%
|
126
|
%
|
|
Selling, general and administrative
|
86
|
%
|
95
|
%
|
|
81
|
%
|
93
|
%
|
|
Loss from operations
|
(117
|
)%
|
(202
|
)%
|
|
(113
|
)%
|
(185
|
)%
|
|
|
|
|
|
|
|
||||
|
Interest expense
|
(1
|
)%
|
(1
|
)%
|
|
(1
|
)%
|
(1
|
)%
|
|
Interest income and other (expense), net
|
—
|
%
|
(1
|
)%
|
|
—
|
%
|
—
|
%
|
|
Loss before income taxes
|
(118
|
)%
|
(204
|
)%
|
|
(114
|
)%
|
(186
|
)%
|
|
Provision for income taxes
|
1
|
%
|
1
|
%
|
|
1
|
%
|
2
|
%
|
|
Net loss
|
(119
|
)%
|
(205
|
)%
|
|
(115
|
)%
|
(188
|
)%
|
|
|
Three Months Ended
|
|
|
|
|
|||||||||||||||
|
|
July 2, 2017
|
|
July 3, 2016
|
|
Change
|
|||||||||||||||
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
Revenue by product line
(1)
:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
New products
|
$
|
1,491
|
|
|
49
|
%
|
|
$
|
1,197
|
|
|
44
|
%
|
|
$
|
294
|
|
|
25
|
%
|
|
Mature products
|
1,535
|
|
|
51
|
%
|
|
1,520
|
|
|
56
|
%
|
|
15
|
|
|
1
|
%
|
|||
|
Total revenue
|
$
|
3,026
|
|
|
100
|
%
|
|
$
|
2,717
|
|
|
100
|
%
|
|
$
|
309
|
|
|
11
|
%
|
|
|
Three Months Ended
|
|
|
|
|
|||||||||||||||
|
|
July 2, 2017
|
|
July 3, 2016
|
|
Change
|
|||||||||||||||
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
Revenue
|
$
|
3,026
|
|
|
100
|
%
|
|
$
|
2,717
|
|
|
100
|
%
|
|
$
|
309
|
|
|
11
|
%
|
|
Cost of revenue
|
1,646
|
|
|
54
|
%
|
|
1,941
|
|
|
71
|
%
|
|
(295
|
)
|
|
(15
|
)%
|
|||
|
Gross Profit
|
$
|
1,380
|
|
|
46
|
%
|
|
$
|
776
|
|
|
29
|
%
|
|
$
|
604
|
|
|
78
|
%
|
|
|
Three Months Ended
|
|
|
|
|
|||||||||||||||
|
|
July 2, 2017
|
|
July 3, 2016
|
|
Change
|
|||||||||||||||
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
R&D expense
|
$
|
2,319
|
|
|
77
|
%
|
|
$
|
3,683
|
|
|
136
|
%
|
|
$
|
(1,364
|
)
|
|
(37
|
)%
|
|
SG&A expense
|
2,614
|
|
|
86
|
%
|
|
2,591
|
|
|
95
|
%
|
|
23
|
|
|
1
|
%
|
|||
|
Total operating expenses
|
$
|
4,933
|
|
|
163
|
%
|
|
$
|
6,274
|
|
|
231
|
%
|
|
$
|
(1,341
|
)
|
|
(21
|
)%
|
|
|
Three Months Ended
|
|
Change
|
|||||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
Amount
|
|
Percentage
|
|||||||
|
Interest expense
|
$
|
(21
|
)
|
|
$
|
(34
|
)
|
|
$
|
13
|
|
|
(38
|
)%
|
|
Interest income and other (expense), net
|
1
|
|
|
(15
|
)
|
|
16
|
|
|
(107
|
)%
|
|||
|
|
$
|
(20
|
)
|
|
$
|
(49
|
)
|
|
$
|
29
|
|
|
(59
|
)%
|
|
|
Three Months Ended
|
|
Change
|
|||||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
Amount
|
|
Percentage
|
|||||||
|
Provision for income taxes
|
$
|
34
|
|
|
$
|
27
|
|
|
$
|
7
|
|
|
26
|
%
|
|
|
Six Months Ended
|
|
|
|
|
|||||||||||||||
|
|
July 2, 2017
|
|
July 3, 2016
|
|
Change
|
|||||||||||||||
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
Revenue by product line
(1)
:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
New products
|
3,403
|
|
|
55
|
%
|
|
$
|
2,689
|
|
|
47
|
%
|
|
$
|
714
|
|
|
27
|
%
|
|
|
Mature products
|
2,793
|
|
|
45
|
%
|
|
2,978
|
|
|
53
|
%
|
|
(185
|
)
|
|
(6
|
)%
|
|||
|
Total revenue
|
$
|
6,196
|
|
|
100
|
%
|
|
$
|
5,667
|
|
|
100
|
%
|
|
$
|
529
|
|
|
9
|
%
|
|
|
Six Months Ended
|
|
|
|
|
|||||||||||||||
|
|
July 2, 2017
|
|
July 3, 2016
|
|
Change
|
|||||||||||||||
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
Revenue
|
$
|
6,196
|
|
|
100
|
%
|
|
$
|
5,667
|
|
|
100
|
%
|
|
$
|
529
|
|
|
9
|
%
|
|
Cost of revenue
|
3,443
|
|
|
56
|
%
|
|
3,735
|
|
|
66
|
%
|
|
(292
|
)
|
|
(8
|
)%
|
|||
|
Gross Profit
|
$
|
2,753
|
|
|
44
|
%
|
|
$
|
1,932
|
|
|
34
|
%
|
|
$
|
821
|
|
|
42
|
%
|
|
|
Six Months Ended
|
|
|
|
|
|||||||||||||||
|
|
July 2, 2017
|
|
July 3, 2016
|
|
Change
|
|||||||||||||||
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
% of Total
Revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
R&D expense
|
$
|
4,746
|
|
|
77
|
%
|
|
$
|
7,130
|
|
|
126
|
%
|
|
$
|
(2,384
|
)
|
|
(33
|
)%
|
|
SG&A expense
|
5,028
|
|
|
81
|
%
|
|
5,284
|
|
|
93
|
%
|
|
(256
|
)
|
|
(5
|
)%
|
|||
|
Total operating expenses
|
$
|
9,774
|
|
|
158
|
%
|
|
$
|
12,414
|
|
|
219
|
%
|
|
$
|
(2,640
|
)
|
|
(21
|
)%
|
|
|
Six Months Ended
|
|
Change
|
|||||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
Amount
|
|
Percentage
|
|||||||
|
Interest expense
|
$
|
(82
|
)
|
|
$
|
(72
|
)
|
|
$
|
(10
|
)
|
|
14
|
%
|
|
Interest income and other (expense), net
|
1
|
|
|
(22
|
)
|
|
23
|
|
|
(105
|
)%
|
|||
|
|
$
|
(81
|
)
|
|
$
|
(94
|
)
|
|
$
|
13
|
|
|
(14
|
)%
|
|
|
Six Months Ended
|
|
Change
|
|||||||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
|
Amount
|
|
Percentage
|
|||||||
|
Provision for income taxes
|
$
|
70
|
|
|
$
|
91
|
|
|
$
|
(21
|
)
|
|
(23
|
)%
|
|
|
Six Months Ended
|
||||||
|
|
July 2,
2017 |
|
July 3,
2016 |
||||
|
Net cash used in operating activities
|
$
|
(7,758
|
)
|
|
$
|
(9,562
|
)
|
|
Net cash used in investing activities
|
(48
|
)
|
|
(1,513
|
)
|
||
|
Net cash provided by financing activities
|
15,170
|
|
|
10,909
|
|
||
|
|
Payments Due by Period
|
||||||||||||||
|
|
Total
|
|
Less than
1 Year
|
|
1-3 Years
|
|
More than
3 Years
|
||||||||
|
Contractual obligations:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Operating leases
|
$
|
1,691
|
|
|
$
|
851
|
|
|
$
|
664
|
|
|
$
|
176
|
|
|
Wafer purchases
(1)
|
1,023
|
|
|
1,023
|
|
|
—
|
|
|
—
|
|
||||
|
Other purchase commitments
|
693
|
|
|
667
|
|
|
26
|
|
|
—
|
|
||||
|
Total contractual cash obligations
|
3,407
|
|
|
2,541
|
|
|
690
|
|
|
176
|
|
||||
|
Other commercial commitments
(2)
:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Revolving line of credit
|
6,000
|
|
|
6,000
|
|
|
—
|
|
|
—
|
|
||||
|
Capital lease obligations
(3)
|
296
|
|
|
167
|
|
|
129
|
|
|
—
|
|
||||
|
Total commercial commitments
|
6,296
|
|
|
6,167
|
|
|
129
|
|
|
—
|
|
||||
|
Total contractual obligations and commercial commitments
|
$
|
9,703
|
|
|
$
|
8,708
|
|
|
$
|
819
|
|
|
$
|
176
|
|
|
(1)
|
Certain of our wafer manufacturers require us to forecast wafer starts several months in advance. We are committed to accept the delivery of and pay for a portion of forecasted wafer volume. Wafer and finished goods purchase commitments of
$1.0 million
include firm purchase commitments as of
July 2, 2017
.
|
|
(2)
|
Other commercial commitments are included as liabilities on our balance sheet as of
July 2, 2017
.
|
|
(3)
|
For a detailed explanation, see Note 5 to the Condensed Unaudited Consolidated Financial Statements.
|
|
Exhibit
Number
|
|
Description
|
|
31.1
|
|
Certification of Brian C. Faith, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
|
Certification of Suping (Sue) Cheung, Chief Financial Officer , pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1
|
|
Certification of Brian C. Faith, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2
|
|
Certification of Suping (Sue) Cheung, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
QUICKLOGIC CORPORATION
|
|
|
|
|
|
|
|
/s/ Suping (Sue) Cheung
|
|
Date:
|
August 10, 2017
|
Suping (Sue) Cheung
|
|
|
|
Chief Financial Officer
(as Principal Accounting and Financial Officer and on behalf of the
Registrant)
|
|
Exhibit
Number
|
|
Description
|
|
31.1
|
|
Certification of Brian C. Faith, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
|
Certification of Suping (Sue) Cheung, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1
|
|
Certification of Brian C. Faith, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2
|
|
Certification of Suping (Sue) Cheung, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|